GLOBAL CANINE INFLUENZA VACCINE MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2024-2031)

Global Canine Influenza Vaccine Market, By Vaccine Type (Recombinant Vaccines, Inactivated Vaccines, and Others), By Virus Type (H3N8 virus and H3N2 virus), By Distribution Channel (Public and Private), By Geography (North America, Europe, Asia Pacific, Latin America, Middle East and Africa)

Published In : Apr 2024
Code : CMI6932
Pages :169
Formats :
Excel and PDF
Industry : Biotechnology

Market Challenges – Stringent Regulations for Veterinary Vaccines

Regulatory authorities across countries have implemented strict norms and guidelines for the development, manufacturing, and approval of new veterinary vaccines to ensure safety, efficacy, and quality. Complying with these complex regulations involves extensive clinical trials, comprehensive documentation, and significant investments of both time and funds. This lengthens the overall product development lifecycle considerably and delays the market introduction of new canine influenza vaccines.

Market Opportunities – Increasing Awareness of Animal Health and Welfare

Increasing awareness of animal health and welfare and shifts in demographics and lifestyles leading to increased spending on pet healthcare. Various awareness programs are being organized in different regions to educate pet owners about animal disease diagnosis, treatment, and aftercare of canine atopic dermatitis which impacts the market positively. For instance, in May 2021, the American Pet Products Association (APPA) announced the launch of its “Pet Feels” campaign, the newest initiative for the association’s Pets Add Life (PAL) program.